Inactive Instrument

Regent Pacific Group Ltd. Stock Hong Kong S.E.

Equities

0575

KYG7478U1388

Pharmaceuticals

Financials

Sales 2022 35K 273K 47.87K Sales 2023 291K 2.27M 398K Capitalization 18.13M 142M 24.8M
Net income 2022 -36M -281M -49.24M Net income 2023 -25M -195M -34.19M EV / Sales 2022 1,045 x
Net Debt 2022 12.29M 95.98M 16.81M Net cash position 2023 1.22M 9.53M 1.67M EV / Sales 2023 58.1 x
P/E ratio 2022
-0.67 x
P/E ratio 2023
-0.71 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 40.23%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 96-03-31
Founder 68 89-12-31
Director of Finance/CFO 49 10-12-31
Members of the board TitleAgeSince
Founder 68 89-12-31
Chief Executive Officer 58 96-03-31
Director/Board Member 80 01-09-30
More insiders
Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.
More about the company